Where Small Things Make Big Impact

Many global experts believe that exosomes have the power to revolutionize multiple global industries. From drug and vaccine development to producing new, non-clinical products like cosmetics, exomes have virtually unlimited potential.

At Exosome Consulting we specialize in helping investors and biopharma companies to identify opportunities and overcome challenges in the field of exosome-based therapies, diagnostics, and services.

Extracellular vesicles (EVs), including exosomes, are tiny lipid-bound sacks secreted by various cells.

EVs measure merely 25-180nm, yet they serve as vital “cargo containers” for cells, performing functions related to cell-to-cell communication, protein delivery, and more. 

Many consider EVs, like exosomes,  perfect delivery systems for next-generation pharmaceuticals, cosmetic products, and more. In fact, it’s estimated that the global market for extracellular vesicle based-products and technologies will exceed $1 billion US by 2030.

As a result, the rapidly developing market for them presents countless opportunities for pharmaceutical companies, investors, and academics to research the exosomes themselves.

 

Reach out to us at [email protected], and we’ll schedule an exploratory call with one of our team members.